Oral ruxolinitib effect on alopecia areata patients: scalp skin - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS5275

Oral ruxolinitib effect on alopecia areata patients: scalp skin

Analysis of scalp skin from two alopecia areata (AA) patients treated with oral ruxolitinib for 12 weeks. AA is a T-cell mediated autoimmune disease. Ruxolitinib is a small-molecule inhibitor of the JAK1/2 kinases. Results provide insight into molecular mechanisms underlying the pathogenesis of AA.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent, 2 disease state, 5 individual, 2 time sets

Platform:: GPL570
Series:: GSE58573
7 Samples

Download data: CEL

DataSet

Accession:: GDS5275

ID:: 5275

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 120264413) (1)
GEO DataSets
Oral ruxolinitib effect on alopecia areata patients: scalp skin
Oral ruxolinitib effect on alopecia areata patients: scalp skin
Accession: GDS5275

GEO DataSets
ribosomal protein L2 (chloroplast) [Bromus diandrus]
ribosomal protein L2 (chloroplast) [Bromus diandrus]
gi|2577876354|ref|YP_010940258.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets